Relevance of Adalimumab Product Attributes to Patient Experience in the Biosimilar Era: A Narrative Review Jessica R. AllegrettiJessica H. BradyAlvin Wells Review Open access 11 March 2024 Pages: 1775 - 1794
‘Totality of Evidence’ Approach in the Development of GP2017, an Approved Adalimumab Biosimilar Norman GaylisCharlotte BothPaul Yamauchi Review Open access 21 March 2024 Pages: 1795 - 1814
Clinical Management of Patients with Non-Small Cell Lung Cancer, Brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review Mustafa KhasrawPriyanka YalamanchiliEnriqueta Felip Review Open access 21 March 2024 Pages: 1815 - 1842
Risk of Stroke in Real-World US Individuals with Type 2 Diabetes Receiving Semaglutide or a Dipeptidyl Peptidase 4 Inhibitor Marc EvansMansoor HusainIldiko Lingvay Original Research Open access 10 February 2024 Pages: 1843 - 1859
The Humanistic and Economic Burden Associated with Major Depressive Disorder: A Retrospective Cross-Sectional Analysis Larry CulpepperAshley MartinMousam Parikh Original Research Open access 11 March 2024 Pages: 1860 - 1884
Comparison of Healthcare Costs for Women with Treated Versus Untreated Vasomotor Symptoms Due to Menopause Aki ShiozawaShayna MancusoHelen M. Trenz Original Research Open access 11 March 2024 Pages: 1885 - 1895
Adverse Drug Events Observed with the Newly Approved Remimazolam in Comparison to Propofol for General Anesthesia in Patients Undergoing Surgery: A Meta-analysis Lidan HuangHong LiuSong Tao Original Research 13 March 2024 Pages: 1896 - 1910
Perioperative and Long-Term Outcomes in Patients Undergoing Synchronous Carotid Endarterectomy and Coronary Artery Bypass Grafting: A Single-Center Experience Paimann NawroziThomas RatschillerAndreas Zierer Original Research Open access 13 March 2024 Pages: 1911 - 1922
Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data Brian G. M. DurieShaji K. KumarThierry Facon Original Research Open access 18 March 2024 Pages: 1923 - 1937
Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor Gilles SallesJenny M. H. ChenBijal Shah Original Research Open access 18 March 2024 Pages: 1938 - 1952
Enhancing Drug Management, Cost Savings, and Staff Satisfaction in Anesthesiology: A Quality Improvement Project in a Chinese Tertiary Hospital Xiaomin XingHaijun QuFanbo Jing Original Research 18 March 2024 Pages: 1953 - 1966
Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study Eun-Gyoung HongKyung-Wan MinHak Chul Jang Original Research Open access 21 March 2024 Pages: 1967 - 1982
Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine Angela T. H. KwanZiji GuoRoger S. McIntyre Original Research 23 March 2024 Pages: 1983 - 1994
Pharmacological Basis of Differences in Dose Response, Dose Equivalence, and Duration of Action of Inhaled Corticosteroids Peter T. Daley-YatesBhumika AggarwalMaximilian Plank Original Research Open access 27 March 2024 Pages: 1995 - 2009
Modelling Treatment Sequences in Immunology: Optimizing Patient Outcomes Rose J. HartFareen HassanDawn Lee Original Research Open access 30 March 2024 Pages: 2010 - 2027
Perceptions and Experiences of People with Obesity and Type 2 Diabetes Around Appetite and Eating Behaviors: A Qualitative Study Jiat Ling PoonLouise OHaraBrad Mason Original Research Open access 01 April 2024 Pages: 2028 - 2049
Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension Study Christopher J. PatriquinAndrija BogdanovicJens Panse Original Research Open access 04 April 2024 Pages: 2050 - 2069
Exploring the Content Validity of the Unified Wilson Disease Rating Scale: Insights from Qualitative Research Stella KarantzoulisKarli HeuerMegan Teynor Original Research Open access 04 April 2024 Pages: 2070 - 2082
Correction to: The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis Awad AlshahraniNaji KholaifMoeber Mahzari Correction Open access 13 March 2024 Pages: 2083 - 2083
Correction to: Comparative Efficacy, Durability and Safety of Faricimab in the Treatment of Diabetic Macular Edema: A Systematic Literature Review and Network Meta-Analysis Claire WatkinsTatiana PauloMarloes Bagijn Correction Open access 13 March 2024 Pages: 2084 - 2085
Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis Benjamin ChastekAdam CarreraDavid Staskin Brief Report Open access 23 March 2024 Pages: 2086 - 2097